References
- World Bank. http://www.worldbank.org/en/country/china/overview#1. [Last accessed 20 June 2017]
- Yang G, Kong L, Zhao W, et al. Emergence of chronic non-communicable diseases in China. Lancet 2008;372:1697-705
- World Health Organization. http://www.who.int/nmh/countries/chn_en.pdf?ua=1. [Last accessed 20 June 2017]
- Li H, Ge J. Cardiovascular diseases in China: current status and future perspectives. Int J Cardiol Heart Vasc 2015;6:25-31
- WHO. Report on the global tobacco epidemic, 2008: The MPOWER package. Geneva: World Health Organization; 2008
- Yang W, Lu J, Weng J, et al. China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101
- Li H, Yan X, Deng X, et al. A cross-sectional study of the prevalence, awareness, treatment and control of hypertension in Shenzhen, China. BMJ Open 2017;7:e015206
- Cai L, Han X, Qi Z, et al. Prevalence of overweight and obesity and weight loss practice among Beijing adults, 2011. PLoS One 2014;9:e98744
- Li J, Li X, Wang Q, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet 2015;385:441-51
- Xu H, Li W, Yang J, et al.; CAMI Registry study group. The China Acute Myocardial Infarction (CAMI) registry: a national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China. Am Heart J 2016;175:193-201.e3
- Wang W, Jiang B, Sun H, et al.; NESS-China Investigators. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation 2017;135:759-71
- Downing NS, Wang Y, Dharmarajan K, et al. Quality of care in Chinese hospitals: processes and outcomes after ST-segment elevation myocardial infarction. J Am Heart Assoc 2017;6:e005040
- Wang L, Wang Y, Jin S, et al. Emergence and control of infectious diseases in China. Lancet 2008;372:1598-605
- Yang S, Wu J, Ding C, et al. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis 2017;17:716-25
- Shaw K. The 2003 SARS outbreak and its impact on infection control practices. Public Health 2006;120:8-14
- WHO. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. Geneva: World Health Organisation; 2008
- Wang D, Cai F. Migration and poverty alleviation in China. Geneva: International Organization for Migration; 2008
- Ren Z, Ge Y, Wang J, et al. Understanding the inconsistent relationships between socioeconomic factors and poverty incidence across contiguous poverty-stricken regions in China: multilevel modeling. Spat Stat 2017;21:406-20
- Tang S, Meng Q, Chen L, et al. Tackling the challenges to health equity in China. Lancet 2008;372:1493-501
- Gwatidzo SD, Stewart Williams J. Diabetes mellitus medication use and catastrophic healthcare expenditure among adults aged 50+ years in China and India: results from the WHO study on global AGEing and adult health (SAGE). BMC Geriatr 2017;17:14
- Liu Y, Rao K, Wu J, et al. China’s health system performance. Lancet 2008;372:1914-23
- Yip WC, Hsiao WC, Chen W, et al. Early appraisal of China’s huge and complex health-care reforms. Lancet 2012;379:833-42
- Meng Q, Fang H, Liu X, et al. Consolidating the social health insurance schemes in China: towards an equitable and efficient health system. Lancet 2015;386:1484-92
- Meng Q, Xu L, Zhang Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet 2012;379:805-14
- Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-39
- Huang Y, Gao L, Xie X, et al Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control. Popul Health Metr 2014;12:28
- Yu W, Shi R, Li J, et al. Need for hyperlipidemia management policy reform in China: learning from the global experience. Curr Med Res Opin 2017 Aug 9:1-11 [Epub ahead of print]